RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > 2020 > 2 > With EU Medical Device Regulation Deadline Looming, Regulatory Pros to Gather in Brussels for RAPS E

With EU Medical Device Regulation Deadline Looming, Regulatory Pros to Gather in Brussels for RAPS Euro Convergence

Posted 14 February 2020 | By Zachary Brousseau 

With EU Medical Device Regulation Deadline Looming, Regulatory Pros to Gather in Brussels for RAPS Euro Convergence

RAPS will host its annual European conference, newly dubbed Euro Convergence 2020, in Brussels, 11–13 May, at the Radisson Blu. The event will draw a broad range of professionals and regulators concerned with the regulation of medical devices, medicines and other healthcare products, and take place just two weeks before the planned implementation of the EU’s extensive overhaul of its rules governing devices, the Medical Device Regulation (EU MDR).
 
While much attention has been focused on the new requirements of the EU MDR and device companies’ readiness as the 26 May implementation deadline approaches, another major change also is on the horizon. The EU In Vitro Diagnostic Regulation (EU IVDR) is set to go into effect in May 2022, and although the deadline is more than two years away and there are fewer IVD manufacturers than device makers, the regulation will bring even more sweeping changes regulated companies must comply with.
 
Expert speakers at Euro Convergence 2020 will cover the most critical issues not only for medical devices and IVDs, but also for pharmaceutical products in Europe. Each area has its own dedicated program track with 24 sessions on device-related topics, 20 on pharmaceuticals and 11 covering IVDs. See the full, interactive agenda.
 
“With the European regulatory community facing so many wide-ranging changes and so much uncertainty, Euro Convergence 2020 is an important opportunity to connect, discuss and exchange ideas and information,” said RAPS Executive Director Paul Brooks. “This is an incredibly supportive community, and I believe we are all on this journey together.”
 
The conference was re-established last year specifically for European professionals as RAPS’ membership in Europe continues to grow. This year, it has been re-branded as Euro Convergence, strengthening the connection with the RAPS Convergence, the largest annual gathering of the regulatory profession.
 
The conference agenda will be updated as additional speakers are confirmed. For those who need more in-depth guidance on several specific key topics, including IVDR and clinical studies in postmarket clinical follow-up, five pre-conference workshops will be held immediately prior the main conference.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe